A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease.
Smits BM, Lelieveld PHC, Ververs FA, Turkenburg M, de Koning C, van Dijk M, Leavis HL, Boelens JJ, Lindemans CA, Bloem AC, van de Corput L, van Montfrans J, Nierkens S, van Gijn ME, Geerke DP, Waterham HR, Koenderman L, Boes M.
Smits BM, et al. Among authors: van de corput l.
Clin Immunol. 2020 Mar;212:108248. doi: 10.1016/j.clim.2019.108248. Epub 2019 Aug 2.
Clin Immunol. 2020.
PMID: 31382036
No abstract available.